MPM Medical Hosts Webinar on MetaMatrix™ Antibacterial Collagen
On February 24, 2025, MPM Medical will present a valuable webinar led by Dr. Bilal Mahmood. This exclusive session focuses on the innovative MetaMatrix™ Antibacterial Collagen, a product that has shown promising results in decreasing surgical site infections (SSIs) during hip and knee arthroplasties. This event comes on the heels of a remarkable clinical study demonstrating the efficacy of this collagen solution.
During the webinar, Dr. Mahmood, who is not only an accomplished orthopedic surgeon but also the author of the clinical study, will delve into the essential findings of the project showcased at the 2024 Current Concepts in Joint Replacement (CCJR®) conference. He aims to provide participants with in-depth insights regarding the clinical application of MetaMatrix™ in surgical practices.
Innovative Insights from the Clinical Study
The study evaluated a total of 285 hip and knee arthroplasties performed while utilizing MetaMatrix™ Antibacterial Surgical Collagen. Remarkably, only a single case of surgical site infection occurred, translating to a low SSI incidence rate of just 0.0035%. This statistic underscores the effectiveness of this product in safeguarding surgical outcomes.
Event Highlights
- - Clinical Study Overview: Attendees will gain a comprehensive understanding of the methodologies, results, and practical implications of integrating MetaMatrix™ in surgical settings.
- - Study Results Presentation: Dr. Mahmood will share critical metrics and feedback derived from the clinical study, emphasizing its success in combating SSIs.
- - Expert Insights: Hear firsthand from Dr. Mahmood about how the adoption of MetaMatrix™ has transformed his surgical practice, as well as explore practical strategies for SSI prevention.
- - Interactive QA Session: Participants will have an opportunity to engage directly with Dr. Mahmood during the live QA, enabling a lively discussion on the insights presented.
About MetaMatrix™ Antibacterial Surgical Collagen
MetaMatrix™ is a Type I Bovine Collagen product that was developed specifically to handle the rigorous demands of surgical applications. Its low pH formula includes antibacterial properties designed to tackle pathogens linked with surgical site infections. Available in both powder and pad forms, this innovative product is applied above the fascia layer to inhibit infection risks while promoting tissue regeneration and supporting wound healing.
The introduction of MetaMatrix™ into surgical practice not only benefits patient outcomes but also aligns with FDA guidelines concerning endotoxin levels for orthopedic procedures.
Why You Should Join
This webinar presents a unique chance for orthopedic surgeons and medical sales representatives to deepen their understanding of collagen's integral role in surgical wound healing. The findings from Dr. Mahmood’s study pave the way for improved safety in surgical operations, particularly in hip and knee procedures.
Secure your spot now to learn actionable strategies that could enhance your practice and contribute to better patient recovery and outcomes.
Event Details
- - Date: Monday, February 24, 2025
- - Time: 6:00 PM – 6:45 PM CST
- - Location: Online
- - Registration: Register here
About MPM Medical
Established in 1992, MPM Medical has been at the forefront of medical innovation, focusing on advanced wound care products that emphasize quality and patient outcomes. Their product line includes not only the MetaMatrix™ Antibacterial Collagen but also other flagship offerings such as RegeneCare HA™ and ExcelSAP™. MPM Medical is committed to advancing healthcare and enhancing patient care through pioneering solutions and dedicated support to healthcare professionals.
For inquiries about their products or to learn more, visit
mpmmed.com.
Contact Information
- - Email: [email protected]
- - Phone: 1-800-232-5512
Don't miss out on this informative session that could change the way you approach surgical infections!